is not consistently high. By varying the initial plating density, we observed that the percentage of cells that differentiate into definitive endoderm (Fig. 1a) can range from 25% to 80% (Fig. 1b and Supplementary Fig. 1a,b) , with the number of Sox17 + cells varying by as much as sevenfold (Supplementary Fig. 1c ). Cells were more responsive to differentiation signals if the differentiation protocol began with cells plated at a high density. We hypothesized that promoting contact-mediated growth inhibition in hESCs, as in high-density cultures, might improve their response to differentiation signals.
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DMSO treatment has been shown to enhance contact inhibition and reversibly arrest cells in early G1 in other cultured cell lines [12] [13] [14] [15] . In addition, pleiotropic effects of DMSO, including on the spontaneous differentiation of embryoid bodies, have been noted in various cultured cell types 16, 17 .
We assessed the effects of DMSO treatment on the differentiation potential of low-and high-density HUES8 cultures. The cultures were treated with 1% or 2% DMSO for 24 h and subsequently induced to differentiate into definitive endoderm. In low-density cultures, exposure to DMSO doubled responsiveness to differentiation signals ( Fig. 1b and Supplementary Fig. 1d ), increasing the percentage of Sox17 + cells from ~25% to 50%. DMSO treatment of high-density HUES8 cultures resulted in high efficiencies comparable to those of control cultures (Fig. 1b) .
Next we investigated the effect of DMSO treatment on HUES6, a cell line with low propensity to make definitive endoderm even at high density 1, 2 (Fig. 1c) . Treatment of HUES6 cells with 2% DMSO for 24 h before the onset of differentiation increased Sox17 + cells from ~20% to 50% ( Fig. 1d and Supplementary Fig. 1e ). The H1 cell line is also predicted to have one of the lowest propensities to differentiate toward the endodermal germ layer 2 ; DMSO treatment induced ~90% of H1 cells to become Sox17 + definitive endoderm (Supplementary Figs. 2c and 3a,b) . In all three lines, cells that failed to differentiate retained expression of pluripotency markers under control and DMSO conditions (Supplementary Fig. 2 ).
Next we assessed whether an initial DMSO treatment could improve terminal differentiation in HUES6. A 24-h DMSO treatment substantially improved HUES6 differentiation into Pdx1 + pancreatic progenitors (~60%, Fig. 1d ) and terminally differentiated hormone-expressing C-peptide + cells to levels similar to those seen for the high-propensity HUES8 cell line 11 ( Supplementary Fig. 1f ). Other terminal cell types induced by this protocol were not assessed.
HUES6 is also predicted to be impaired in its ability to differentiate into the ectodermal (neural) and mesodermal lineages 1 We describe a method to help overcome restrictions on the differentiation propensities of human pluripotent stem cells. culturing pluripotent stem cells in dimethylsulfoxide (dmso) activates the retinoblastoma protein, increases the proportion of cells in the early G1 phase of the cell cycle and, in more than 25 embryonic and induced pluripotent stem cell lines, improves directed differentiation into multiple lineages. dmso treatment also improves differentiation into terminal cell types in several cell lines.
The differentiation potential of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) varies substantially across cell lines. Certain cell lines have a higher capacity to differentiate into derivatives of some germ layers 1, 2 . Based on differences in gene expression and DNA methylation profiles, a 'lineage scorecard' has been described that predicts the differentiation potential of 32 hESC and hiPSC lines 2 . This has led to the view that particular cell lines need to be selected to achieve efficient differentiation to a lineage of choice.
We investigated the role of the cell cycle on differentiation potential and present a new perspective, challenging the view that only some human pluripotent stem cell lines are suitable for differentiation into particular lineages. hESC and hiPSC lines have a cellcycle structure characterized by an abbreviated G1 gap phase and minimal checkpoint controls [3] [4] [5] [6] . Similarly, in early development in vivo, the embryonic cell cycle also has a truncated G1 phase during the period when rapid cell division occurs and decisions about fate and differentiation are held back [7] [8] [9] [10] . These findings suggest that the absence of an early G1 phase is associated with self-renewal and that the presence of this phase is associated with differentiation and cell fate changes. This led us to investigate whether the presence of an early G1 phase and its associated checkpoint controls are important for directed differentiation of pluripotent cell lines.
We began our analysis by investigating the hESC line HUES8. HUES8 has one of the highest propensities for differentiation to Sox17 + definitive endoderm cells 1, 11 , yet its differentiation Supplementary Fig. 6 ), enhancing functionality in a cell line previously considered incompetent 2 .
We evaluated the effects of an initial DMSO treatment on terminal differentiation in two additional contexts. In low-density cultures, HUES8 cells that had differentiated into definitive endoderm failed to differentiate further into Pdx1 + cells, and cell survival was substantially compromised (Fig. 1d,e ). An initial 24-h DMSO treatment enhanced pancreatic differentiation in these low-density cultures, yielding 60% Pdx1 + cells, comparable to the efficiency of high-density cultures ( Fig. 1d-f ). DMSO treatment of low-density HUES8 cultures also promoted further terminal differentiation into C-peptide + and glucagon + endocrine cells (Supplementary Fig. 7) .
Because Pdx1 + cells may be a source for cell replacement therapy for diabetes [18] [19] [20] , we assessed the effects of DMSO in an induced pluripotent stem cell line derived from a type 1 diabetic subject (DiPS). Although DiPS control cultures efficiently (~60%) differentiated toward definitive endoderm, further differentiation to Pdx1 + cells was inefficient (0.4%) even at high density. An initial 24-h DMSO treatment increased differentiation to Pdx1 + cells by 100-fold, from 0.4% to 44% (Fig. 1d,g ).
We tested the effect of DMSO on differentiation across lineages in more than 25 other human pluripotent cell lines, including those used to generate the lineage scorecard 2 . DMSO treatment enhanced directed differentiation ( Fig. 2a) into cells of all three germ layers (Fig. 2b,c 20% ± 6% 23% ± 6% 50% ± 1% 61% ± 5% 28% ± 0.05% 54% ± 3% 60% ± 0.5% Table 1 ) and in total yield of cells (Supplementary Table 2 ). The effects of DMSO were particularly large in poorly performing cell lines ( Supplementary  Fig. 8a ). For instance, HUES1 is predicted to have low differentiation potential for ectoderm as a result of suppressed expression of ectodermal-related genes 2 . DMSO treatment raised the ectodermal differentiation potential of HUES1 from 28% to 93% ( Supplementary  Fig. 8b,c and Supplementary Table 1) . Hence, DMSO treatment raises the minimum differentiation potential across all germ layers and reduces the probability of a very low differentiation rate.
The average cycling times of hESC and hiPSC lines range from ~24 to 48 h (refs. 21, 22) . Because growth inhibition is associated with cell cycling time, we assessed DMSO effects on differentiation following a 24-or 48-h treatment. We observed that extending treatment from 24 to 48 h improved differentiation for several cell lines and that optimizing the DMSO treatment could result in 80%-90% differentiation in some cases (Supplementary Fig. 9 ).
In several of the cell lines tested, we observed that DMSO treatment positively affected differentiation further down the endocrine lineage, resulting in enhanced induction of Pdx1 + pancreatic progenitor cells (Supplementary Fig. 10a ). Although the effect varied depending on the line, an initial 24-h DMSO treatment enhanced Pdx1 + cell induction on average by 15-fold and 5-fold in hESC and hiPSC lines, respectively (Supplementary Fig. 10b,c) . Notably, in cell lines with high differentiation efficiencies to Sox17 + definitive endoderm, DMSO improved differentiation into Pdx1 + cells despite having modest impacts at the initial stages of differentiation. Similarly, in the H1 cell line, DMSO treatment promoted generation of terminally differentiated endocrine cells (Supplementary Fig. 3c,d ) to levels comparable to those reported for high-propensity cell lines 18, 19 .
In addition to these persistent effects, preliminary data show that DMSO treatment can improve functionality after transplantation in vivo. Transplantation of control and DMSO-pretreated HUES8 pancreatic progenitor cells under the kidney capsule of SCID-Beige mice showed that an initial 24-h DMSO treatment (prior to directed differentiation in vitro) improved insulin secretion in response to glucose stimulation (data not shown).
We investigated the mechanisms by which DMSO treatment enhances the response of pluripotent stem cells to differentiation signals (Fig. 3) . We focused on the HUES6 line for this analysis because it exhibited the greatest improvements in differentiation potential. Consistent with reports in other tissue culture systems [12] [13] [14] [15] , flow cytometry analysis of propidium iodide-stained HUES6 cells showed that a 24-h 2% DMSO treatment almost doubled the proportion of cells in G1 (Fig. 3a) . To discriminate between cells in early and late G1, we also assessed the presence of the active hypophosphorylated retinoblastoma (Rb) protein, a marker of the early G1 phase 9, 23 . DMSO treatment was associated with a fourfold increase in immunofluorescence reactivity of hypophosphorylated Rb (Fig. 3b) and substantially reduced levels of the phosphorylated and hyperphosphorylated forms of the Rb protein (Fig. 3c,d) . Similarly, for HUES8 cells, higher initial plating density was associated with an increased proportion of cells in G1 (Fig. 3f) and reduced levels of the phosphorylated and hyperphosphorylated forms of the Rb protein (Fig. 3g) .
We performed live imaging of HUES6 cells during a 24-h DMSO treatment and subsequent release. DMSO-treated cultures had a slow growth rate and subsequently reached the same degree of confluence as control cultures upon release from DMSO treatment (Supplementary Fig. 11 ). When cell contact was disrupted, DMSO pretreatment no longer had an impact on differentiation (Fig. 3e) , a result analogous to observations in other cell types in which loss of cell-to-cell contact is associated with inactivation of Rb and impaired differentiation 24 . Prolonged or permanent cell-cycle arrest also inhibited DMSOenhanced differentiation potential (Supplementary Fig. 12) , suggesting that opposing mechanisms may govern spontaneous extraembryonic differentiation 25, 26 and directed differentiation of pluripotent stem cells.
In summary, the results presented here challenge the view that only some human pluripotent stem cell lines are suitable for differentiation into particular lineages. Culturing hESCs and hiPSCs in DMSO for a brief period (24-48 h) can improve the ability of several cell lines to differentiate into the desired lineage. This method also enhances the prospects of using patient-specific 17 , DMSO concentrations of 1%-2% did not have any toxic effects on hESCs and hiPSCs. Moreover, the effects of an initial DMSO treatment persist to improve functionality. Although further work is needed to characterize the mechanism through which DMSO operates, our analysis suggests that DMSO likely improves differentiation by regulating Rb and the pluripotent cell cycle. Rb plays a key role in a variety of cellular processes, including tumorigenesis, senescence, apoptosis, DNA damage and repair, and genetic stability 9, 10, [27] [28] [29] . Regulation of Rb activity using DMSO could have applications in many settings. methods Methods and any associated references are available in the online version of the paper.
potential. With the Cellomics high-content screening system, 30 10× fields per well were acquired and quantified. Cells labeled by antibody staining and total cell number (based on DAPI nuclei staining) were quantified to obtain percentages of target cell types. according to the manufacturer's instructions. cDNA (100-120 ng) was amplified by PCR using TaqMan Universal Master Mix and TaqMan Gene Expression assays that were preloaded onto custom TaqMan arrays (Applied Biosystems). Data were analyzed using sequence detection software (Applied Biosystems) and normalized to undifferentiated hESCs using the ∆∆Ct method. A list of primers (Applied Biosystems) is provided in ref. 36 .
Live-cell imaging. Phase-contrast imaging of cultures undergoing a 24-h DMSO treatment followed by a 24-h release in hESC maintenance medium was acquired using the IncuCyte live-cell imaging system.
Cell-cycle analysis. Cells were trypsinized and fixed in 100% EtOH for 30 min on ice, treated with RNase A (100 µg/ml, Qiagen) and stained with propidium iodide (PI; 50 µg/ml, Invitrogen) in 0.1% Triton X-100 for at least 30 min. Cells were assessed on the BD Biosciences LSRII FACS flow cytometer and analyzed using the FlowJo software.
Western blot analysis. Cells were lysed using the RIPA Lysis Buffer (Santa Cruz). Proteins were separated by 7.5% SDS-PAGE (Bio-Rad) and transferred to nitrocellulose membranes (Bio-Rad). The membranes were blocked in 5% skim milk in 0.1% Triton X-100 for 1 h at room temperature and then incubated with the following primary antibodies overnight at 4 °C: G3-245 (ppRb, 1:1,000, BD Pharmingen), Phospho-Rb-Ser780 (1:200, Cell Signaling), Phospho-Rb-Ser795 (1:200, Cell Signaling), PhosphoRb-Ser807/811 (1:200, Cell Signaling), 4H1 (total Rb, 1:1,000, Cell Signaling or GAPDH (1:5,000, Abcam) as the loading control. After washing, the membranes were incubated with secondary antibodies for 1 h at room temperature: anti-mouse HRP (1:1,000, Cell Signaling) or anti-rabbit HRP (1:1,000, Cell Signaling), and then incubated in Chemiluminescent HRP substrate (Millipore) for signal detection and development.
Statistical analysis. Means and s.e.m. were determined for the above variables. For statistical comparisons, these values were subjected to unpaired or paired (across multiple cell lines) two-tailed Student's t-tests. P values ≤0.05 were considered significant.
